Literature DB >> 11290538

Growth hormone receptor is expressed in human breast cancer.

M Gebre-Medhin1, L G Kindblom, H Wennbo, J Törnell, J M Meis-Kindblom.   

Abstract

Several clinical observations and experimental studies indicate that pituitary hormones, including growth hormone, play a role in the development of human breast cancer. We analyzed 48 human breast carcinomas using reverse transcription polymerase chain reaction, immunohistochemistry, and Western blotting techniques to assess growth hormone receptor expression. In 17 of these cases, adjacent normal breast tissue was similarly analyzed. These analyses revealed that growth hormone receptor (GHR) is expressed in human breast cancer and appears to be up-regulated compared to adjacent normal breast tissue. GHR expression correlated inversely with tumor grade and MIB-1 index. Progesterone receptor expression correlated positively with GHR expression. These findings, along with our observation of GHR expression in breast cancer stromal cells and previous reports of local production of growth hormone in breast carcinoma, suggest that GHR-mediated signaling pathways are involved in the development of human breast cancer, possibly via autocrine or paracrine mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290538      PMCID: PMC1891910          DOI: 10.1016/S0002-9440(10)64071-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Acromegaly.

Authors:  A Colao; B Merola; D Ferone; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

2.  Subpopulations of stromal cells from long-term human bone marrow cultures: ontogeny of progenitor cells and expression of growth hormone receptors.

Authors:  D T Lincoln; F Sinowatz; S Gabius; H J Gabius; L Temmim; H Baker; T C Mathew; M J Waters
Journal:  Anat Histol Embryol       Date:  1997-03       Impact factor: 1.114

Review 3.  Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly.

Authors:  S Melmed; K Ho; A Klibanski; S Reichlin; M Thorner
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

4.  Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.

Authors:  H Wennbo; M Gebre-Medhin; A Gritli-Linde; C Ohlsson; O G Isaksson; J Törnell
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

5.  Expression of prolactin and its receptor in human breast carcinoma.

Authors:  C Reynolds; K T Montone; C M Powell; J E Tomaszewski; C V Clevenger
Journal:  Endocrinology       Date:  1997-12       Impact factor: 4.736

6.  Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development.

Authors:  P D Walden; W Ruan; M Feldman; D L Kleinberg
Journal:  Endocrinology       Date:  1998-02       Impact factor: 4.736

7.  Growth hormone treatment induces mammary gland hyperplasia in aging primates.

Authors:  S T Ng; J Zhou; O O Adesanya; J Wang; D LeRoith; C A Bondy
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

8.  Expression of the gene encoding growth hormone in the human mammary gland.

Authors:  J A Mol; S C Henzen-Logmans; P Hageman; W Misdorp; M A Blankenstein; A Rijnberk
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

9.  Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines.

Authors:  G Fuh; J A Wells
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

10.  Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer.

Authors:  C Decouvelaere; J P Peyrat; J Bonneterre; J Djiane; H Jammes
Journal:  Cell Growth Differ       Date:  1995-04
View more
  30 in total

1.  Transcriptomic "portraits" of canine mammary cancer cell lines with various phenotypes.

Authors:  M Król; K M Pawłowski; J Skierski; P Turowski; A Majewska; J Polańska; M Ugorski; R E Morty; T Motyl
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.

Authors:  M D Landis; D D Seachrist; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

Review 3.  Differential action of glycoprotein hormones: significance in cancer progression.

Authors:  Vijayakumar Govindaraj; Swathy V Arya; A J Rao
Journal:  Horm Cancer       Date:  2013-10-16       Impact factor: 3.869

Review 4.  Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency.

Authors:  Jaime Guevara-Aguirre; Arlan L Rosenbloom
Journal:  Diabetologia       Date:  2014-10-15       Impact factor: 10.122

5.  βTrCP controls GH receptor degradation via two different motifs.

Authors:  Ana C da Silva Almeida; Ger J Strous; Agnes G S H van Rossum
Journal:  Mol Endocrinol       Date:  2011-10-27

Review 6.  Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.

Authors:  Harsh Patel; Victor Arruarana; Lucille Yao; Xiaojiang Cui; Edward Ray
Journal:  Endocrine       Date:  2020-02-17       Impact factor: 3.633

7.  Growth hormone receptor expression in human colorectal cancer.

Authors:  Xiaodong Yang; Fukun Liu; Zhe Xu; Che Chen; Gang Li; Xiaoyu Wu; Jieshou Li
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

8.  In vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probe.

Authors:  Shaojuan Zhang; Pin Shao; Mingfeng Bai
Journal:  Bioconjug Chem       Date:  2013-10-29       Impact factor: 4.774

Review 9.  Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.

Authors:  Josué Barahona-Garrido; Jorge Hernández-Calleros; Ignacio García-Juárez; Jesús K Yamamoto-Furusho
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

10.  Growth hormone promotes lymphangiogenesis.

Authors:  Nadja Erika Banziger-Tobler; Cornelia Halin; Kentaro Kajiya; Michael Detmar
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.